Case
Praktijkopdracht farmacotherapie praktijkleerjaar 2
In dit document wordt een opdracht farmacotherapie uitgewerkt van 3 patiënten in het kader van de opleiding tot verpleegkundig specialist (2e jaar). Het six-step model wordt als basis gebruikt.
[Show more]
Preview 3 out of 25 pages
Uploaded on
October 25, 2020
Number of pages
25
Written in
2019/2020
Type
Case
Professor(s)
Unknown
Grade
8
six step model
6 step model
praktijkopdracht 5
farmacotherapie
verpleegkundig specialist
vs ggz
ggz
praktijkopdracht farmacotherapie
verpleegkundig specialist ggz
vs
Book Title: Molemans praktische psychofarmacologie
Author(s): Naarding
Edition: Unknown
ISBN: 9789085621423
Edition: 1
Institution
Opleidingsinstelling Geestelijke Gezondheidszorg Verpleegkundig Specialist
Education
Opleiding tot verpleegkundig specialist ggz
Course
Farmacotherapie
All documents for this subject (1)
$9.14
Also available in package deal from $86.59
Added
Add to cart
Add to wishlist
100% satisfaction guarantee
Immediately available after payment
Both online and in PDF
No strings attached
Also available in package deal (1)
Totaalbundel VS GGZ opleiding
$ 148.89
$ 86.59
16 items
1. Thesis - Gevolgen van social defeat bij schizofrenie (praktijkleerjaar 1)
2. Case - Praktijkopdracht farmacotherapie praktijkleerjaar 1
3. Case - Praktijkopdracht behandelverantwoordelijkheid praktijkleerjaar 1
4. Case - Project analyse in het kader van de praktijkopdracht optimaliseren van zorg (praktijk...
5. Case - Praktijkopdracht behandelverantwoordelijkheid praktijkleerjaar 2
6. Case - Praktijkopdracht farmacotherapie praktijkleerjaar 2
7. Other - Halfjaarlijkse evaluatie met canmeds praktijkleerjaar 1
8. Other - Eindevaluatie praktijkleerjaar 1 van de opleiding verpleegkundig specialist ggz
9. Other - Tussenevaluatie opleiding verpleegkundig specialist ggz praktijkleerjaar 2
10. Other - Eindevaluatie verpleegkundig specialist ggz praktijkleer jaar 2
11. Other - Tussenevaluatie opleiding verpleegkundig specialist ggz praktijkleerjaar 3
12. Other - Eindevaluatie van de opleiding verpleegkundig specialist ggz praktijkleerjaar 3
13. Case - Praktijkopdracht farmacotherapie praktijkleerjaar 3
14. Case - Meesterproef: commitment en verslaving bij ptss (n=1) praktijkleerjaar 3
15. Thesis - De relatie tussen vermoeidheid en kwaliteit van leven bij patiënten met een psychoti...
16. Other - Projectanalyse en projectplan van praktijkleer jaar 3
Show more
Farmacotherapie
Praktijkopdracht 5
farmacotherapie
,INHOUD
1. Six-stepmodel Casus 1: Jos van Vliet ................................................................................................................... 3
1.1 Probleem van de patiënt ............................................................................................................................... 3
1.1.1 Beschrijvende diagnose .......................................................................................................................... 3
1.1.2 DSM-5 classificatie ................................................................................................................................. 3
1.1.3 Behandelgeschiedenis ............................................................................................................................ 3
1.1.4 Somatiek................................................................................................................................................. 4
1.1.5 Huidige medicatie.................................................................................................................................. 4
1.1.6 Evaluatie bestaande therapie ................................................................................................................ 4
1.2 Doel van de behandeling ............................................................................................................................... 4
1.3 Behandelingsmogelijkheden ......................................................................................................................... 5
1.3.1 Niet medicamenteus .............................................................................................................................. 5
1.3.2 Medicamenteus ..................................................................................................................................... 5
1.4 Selectiegeschikte ........................................................................................................................................... 5
1.4.1 Psychostimulantia .................................................................................................................................. 5
1.4.2 Niet stimulerende medicatie .................................................................................................................. 6
1.5 Defintieve behandeling ................................................................................................................................. 6
1.5.1 Contra-indicaties en bijwerkingen ......................................................................................................... 6
1.5.2 Interacties .............................................................................................................................................. 7
1.6 Controleplan en vervolg ................................................................................................................................ 8
1.6.1 controles ................................................................................................................................................ 8
1.6.2 Vervolg ................................................................................................................................................... 8
1.6.3 Vervolgbehandeling ............................................................................................................................... 8
2. Six-stepmodel casus 2: Sofia Sadowski ............................................................................................................... 9
2.1 Probleem van de patiënt ............................................................................................................................... 9
2.1.1 Beschrijvende diagnose .......................................................................................................................... 9
2.1.2 DSM-5 classificatie ................................................................................................................................. 9
2.1.3 Behandelgeschiedenis ............................................................................................................................ 9
2.1.4 Somatiek............................................................................................................................................... 10
2.1.5 Huidige medicatie ................................................................................................................................ 10
2.1.6 Evaluatie bestaande therapie .............................................................................................................. 11
2.2 Doel van de behandeling ............................................................................................................................. 11
2.3 Behandelingsmogelijkheden ....................................................................................................................... 11
2.3.1 Niet medicamenteus ............................................................................................................................ 11
2.3.2 Medicamenteus ................................................................................................................................... 11
2.4 Selectiegeschikte ......................................................................................................................................... 11
1
, 2.5 Defintieve behandeling ............................................................................................................................... 12
2.5.1 Lamotrigine .......................................................................................................................................... 12
2.5.2 Contra-indicaties en bijwerkingen ....................................................................................................... 12
2.5.3 Interacties ............................................................................................................................................ 13
2.6 Controleplan en vervolg .............................................................................................................................. 13
2.6.1 controles .............................................................................................................................................. 13
2.6.2 Vervolg ................................................................................................................................................. 14
2.6.3 Vervolgbehandeling ............................................................................................................................. 14
3. Six-stepmodel Casus 3: Marco Guijt .................................................................................................................. 15
3.1 Probleem van de patiënt ............................................................................................................................. 15
3.1.1 Beschrijvende diagnose ........................................................................................................................ 15
3.1.2 DSM-5 classificatie ............................................................................................................................... 15
3.1.3 Behandelgeschiedenis .......................................................................................................................... 15
3.1.4 Somatiek............................................................................................................................................... 16
3.1.5 Huidige medicatie ................................................................................................................................ 16
3.1.6 Evaluatie bestaande therapie .............................................................................................................. 16
3.2 Doel van de behandeling ............................................................................................................................. 16
3.3 Behandelingsmogelijkheden ....................................................................................................................... 17
3.3.1 Niet medicamenteus ............................................................................................................................ 17
3.3.2 Medicamenteus ................................................................................................................................... 17
3.4 Selectiegeschikte ......................................................................................................................................... 17
3.4.1 Lithium ................................................................................................................................................. 17
3.5 Defintieve behandeling ............................................................................................................................... 18
3.5.1 Contra-indicaties en bijwerkingen ....................................................................................................... 18
3.5.2 Interacties ............................................................................................................................................ 19
3.6 Controleplan en vervolg .............................................................................................................................. 20
3.6.1 controles .............................................................................................................................................. 20
3.6.2 Vervolg ................................................................................................................................................. 21
3.6.3 Vervolgbehandeling ............................................................................................................................. 22
4. Literatuurlijst ..................................................................................................................................................... 23
2